BusinessLine (Kolkata)

Indian families allegedly affected by Covishield to take legal recourse

- PT Jyothi Datta

As AstraZenec­a faces a class action suit in the UK involving the risk of blood clots and low platelet count possibly linked to its Covid-19 vaccine, more families in India are looking to take the legal recourse, said a parent who had lost his 20year old daughter allegedly after taking Covishield.

At least eight a’ected families are in discussion to approach the Supreme Court, as the vaccines were administer­ed despite the companies being aware of the side e’ects in early 2021, G. Venugopala­n, the father of 20-year-old Karunya, told businessli­ne.

In fact, he had gone to court in October 2021 seeking answers from the health authoritie­s on “what happened to our children”, calling for doctors to be educated on the side effects and seeking compensati­on.

But in the light of recent reports from the UK — that AZ said in court, its vaccine could “in very rare cases, cause TTS” — families in India who have been a’ected by the vaccine are going to seek action against the company and authoritie­s involved in the mass vaccinatio­n, he said.

RESPONSE AWAITED

Serum Institute of India makes the AZ vaccine in India, and a response is awaited from it on the developmen­t. AZ had in a recent response on the UK developmen­t said, “regulators around the world consistent­ly state that the benefits of vaccinatio­n outweigh the risks of extremely rare potential side e’ects.”

Venugopala­n pointed out that several European countries, for example, had restricted the use of this vaccine in sections of their population.

In a separate developmen­t, advocate Vishal Tiwari has filed a public interest litigation (PIL) in the SC seeking a vaccine-damage payment system for those severely disabled due to the vaccinatio­n. He has also sought compensati­on for those who had been severely disabled or died because of the side e’ects of the Covid-19 vaccine.

He urged the apex court to set up a medical expert panel comprising medical experts from the All India Institute of Medical Sciences (AIIMSDelhi), headed by its director and supervised by a retired Justice of the SC to examine Covishield and its side e’ects and risk factors. Several families are reaching out, on what they believe are adverse events linked to the vaccine, he told this correspond­ent.

 ?? ??

Newspapers in English

Newspapers from India